{"id":1936,"date":"2024-09-11T20:14:34","date_gmt":"2024-09-11T20:14:34","guid":{"rendered":"https:\/\/onltherapeutics.com\/test\/?page_id=1936"},"modified":"2024-09-13T12:13:01","modified_gmt":"2024-09-13T12:13:01","slug":"board_michal-silverberg","status":"publish","type":"page","link":"https:\/\/onltherapeutics.com\/test\/board_michal-silverberg\/","title":{"rendered":"Board_Michal Silverberg"},"content":{"rendered":"\n<div class=\"wp-block-columns has-background is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\" style=\"border-radius:30px;background-color:#f6f6f6\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading has-contrast-color has-text-color has-background has-link-color wp-elements-73ac4012d607b3a4600648b478c68e3d\" style=\"background-color:#f6f6f6;padding-top:0;padding-right:0;padding-bottom:0;padding-left:0;font-size:clamp(22.041px, 1.378rem + ((1vw - 3.2px) * 2.053), 36px);font-style:normal;font-weight:700\">Michal Silverberg, MBA<\/h3>\n\n\n\n<p class=\"has-background\" style=\"background-color:#f6f6f6;padding-top:0;padding-bottom:0;font-size:clamp(22.041px, 1.378rem + ((1vw - 3.2px) * 2.053), 36px);\">Chairperson<\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column has-global-padding is-layout-constrained wp-container-core-column-is-layout-9c9c133a wp-block-column-is-layout-constrained\" style=\"padding-right:var(--wp--preset--spacing--30);flex-basis:30%\">\n<figure class=\"wp-block-image size-full has-custom-border\"><img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"720\" src=\"https:\/\/onltherapeutics.com\/test\/wp-content\/uploads\/2024\/09\/Silverberg_Michal-edited.png\" alt=\"\" class=\"wp-image-2027\" style=\"border-radius:30px;aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/onltherapeutics.com\/test\/wp-content\/uploads\/2024\/09\/Silverberg_Michal-edited.png 720w, https:\/\/onltherapeutics.com\/test\/wp-content\/uploads\/2024\/09\/Silverberg_Michal-edited-300x300.png 300w, https:\/\/onltherapeutics.com\/test\/wp-content\/uploads\/2024\/09\/Silverberg_Michal-edited-150x150.png 150w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<p style=\"padding-top:0\">Michal Silverberg is a managing director at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Before joining NVF, she was a senior partner at Takeda Ventures and worked at Novo Nordisk in business development and new product commercialization. Since 1998, Michal has held positions in various life science industry sectors, including in the Office of the Chief Scientist of Israel, venture capital, and global pharmaceutical and biotech companies. She received her bachelor&#8217;s degree in economics and business management from Haifa University, her MBA from Tel Aviv University, and her master\u2019s degree in biotechnology from Columbia University in New York.<\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-base-color has-custom-blue-background-color has-text-color has-background has-link-color wp-element-button\" href=\"https:\/\/onltherapeutics.com\/test\/our-board\/\" style=\"border-radius:30px\">Back to Our Board<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Michal Silverberg, MBA Chairperson Michal Silverberg is a managing director at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Before joining NVF, she was a senior partner at Takeda Ventures and worked at Novo Nordisk in business development and new product commercialization. Since 1998, Michal has held positions in various life science industry sectors, including [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"blank","meta":{"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-1936","page","type-page","status-publish","hentry"],"featured_image_urls_v2":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","gform-image-choice-sm":"","gform-image-choice-md":"","gform-image-choice-lg":""},"post_excerpt_stackable_v2":"<p>Michal Silverberg, MBA Chairperson Michal Silverberg is a managing director at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Before joining NVF, she was a senior partner at Takeda Ventures and worked at Novo Nordisk in business development and new product commercialization. Since 1998, Michal has held positions in various life science industry sectors, including in the Office of the Chief Scientist of Israel, venture capital, and global pharmaceutical and biotech companies. She received her bachelor&#8217;s degree in economics and business management from Haifa University, her MBA from Tel Aviv University, and her master\u2019s degree in biotechnology from Columbia University&hellip;<\/p>\n","category_list_v2":"","author_info_v2":{"name":"theo@myriadweb.com","url":"https:\/\/onltherapeutics.com\/test\/author\/theomyriadweb-com\/"},"comments_num_v2":"0 comments","_links":{"self":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/comments?post=1936"}],"version-history":[{"count":7,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1936\/revisions"}],"predecessor-version":[{"id":2076,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1936\/revisions\/2076"}],"wp:attachment":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/media?parent=1936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}